/
/
/

Bacil Pharma Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)18.00
Volume (₹)1.60 L
High (₹)18.58
Upper Circuit18.58
Low (₹)16.82
Lower Circuit16.82
Prev Close17.70
52W High (₹)61.80
Price18.58
52W Low (₹)10.65

Share Market Cap & Key Ratios Overview

M.Cap (₹)25.40 Cr
Div. Yield (%)0.00
PE Ratio38.61
Debt to Equity0.01
Price to Book2.28
Book Value18.60
EPS (TTM)0.46
Face Value10.00
ROE (%)3.19

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
DRREDDY-ANSE
MANKIND-ANSE
BACPHAR-XNSE
LTP
1W Low
1W High
Market cap (₹)
1864-35 (-1.84%)
1840.70
1907.35
4,48,316Cr
9405+305 (3.35%)
9109.80
10000
2,51,737Cr
4928.4+78.4 (1.62%)
4830
4999
1,87,594Cr
1118-3 (-0.27%)
1110.10
1167.20
1,12,618Cr
1380-5 (-0.36%)
1363.95
1397.05
1,10,515Cr
1936+96 (5.22%)
1826.95
1981
1,04,456Cr
1669+15.7 (0.95%)
1638.65
1703.25
97,239Cr
2075-36 (-1.71%)
2060.55
2132.45
95,660Cr
1140.8-13.2 (-1.14%)
1135.20
1161
95,421Cr
2246-82.55 (-3.55%)
2238.95
2330
93,596Cr
18.58+3.28 (21.44%)
15.10
18.58
25Cr

Key Highlights of Bacil Pharma Ltd Balance Sheet

Bacil Pharma Ltd balance sheet discloses shareholders' funds of ₹13.97Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹13.97Cr, and the reserves and surplus of the company is ₹11.46Cr.

The company has its non-current liabilities with total liabilities of ₹25.55Cr as of 2025-03-31.

The current liabilities are ₹16.89Lakh as of 2025-03-31. At the same time, current assets are ₹2.91Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹21.36Cr and tangible assets of 0, provided in the Bacil Pharma Ltd financial statements.